India’s Biocon approves plan to raise $527 million
By Thomson ReutersApr 23, 2025 | 9:45 AM
(Reuters) -Indian biopharma firm Biocon said on Wednesday it will raise funds worth up to 45 billion rupees ($527.3 million) via issue of securities, which may include debt and selling shares to institutional investors.
($1 = 85.3420 Indian rupees)
(Reporting by Hritam Mukherjee in Bengaluru; Editing by Krishna Chandra Eluri)
For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.
